Cargando…

[(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)

PURPOSE: Quantitative in vivo [(18)F]-(2S,4R)4-fluoroglutamine ([(18)F]4-FGln or more simply [(18)F]FGln) metabolic kinetic parameters are compared with activity levels of glutamine metabolism in different types of hepatocellular carcinoma (HCC). METHODS: For this study, we used two transgenic mouse...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Youngho, Craig, Miranda C., Murphy, Stephanie T., Feng, Jinjin, Chen, Xin, Yuneva, Mariia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351703/
https://www.ncbi.nlm.nih.gov/pubmed/35967756
http://dx.doi.org/10.1155/2022/5185951
_version_ 1784762491494989824
author Seo, Youngho
Craig, Miranda C.
Murphy, Stephanie T.
Feng, Jinjin
Chen, Xin
Yuneva, Mariia
author_facet Seo, Youngho
Craig, Miranda C.
Murphy, Stephanie T.
Feng, Jinjin
Chen, Xin
Yuneva, Mariia
author_sort Seo, Youngho
collection PubMed
description PURPOSE: Quantitative in vivo [(18)F]-(2S,4R)4-fluoroglutamine ([(18)F]4-FGln or more simply [(18)F]FGln) metabolic kinetic parameters are compared with activity levels of glutamine metabolism in different types of hepatocellular carcinoma (HCC). METHODS: For this study, we used two transgenic mouse models of HCC induced by protooncogenes, MYC, and MET. Biochemical data have shown that tumors induced by MYC have increased levels of glutamine metabolism compared to those induced by MET. One-hour dynamic [(18)F]FGln PET data were acquired and reconstructed for fasted MYC mice (n = 11 tumors from 7 animals), fasted MET mice (n = 8 tumors from 6 animals), fasted FVBN controls (n = 8 normal liver regions from 6 animals), nonfasted MYC mice (n = 16 tumors from 6 animals), and nonfasted FVBN controls (n = 8 normal liver regions from 3 animals). The influx rate constants (K(1)) using the one-tissue compartment model were derived for each tumor with the left ventricular blood pool input function. RESULTS: Influx rate constants were significantly higher for MYC tumors (K(1) = 0.374 ± 0.133) than for MET tumors (K(1) = 0.141 ± 0.058) under fasting conditions (P = 0.0002). Rate constants were also significantly lower for MET tumors (K(1) = 0.141 ± 0.135) than normal livers (K(1) = 0.332 ± 0.179) under fasting conditions (P = 0.0123). Fasting conditions tested for MYC tumors and normal livers did not result in any significant difference with P values > 0.005. CONCLUSION: Higher influx rate constants corresponded to elevated levels of glutamine metabolism as determined by biochemical assays. The data showed that there is a distinctive difference in glutamine metabolism between MYC and MET tumors. Our study has demonstrated the potential of [(18)F]FGln PET imaging as a tool to assess glutamine metabolism in HCC tumors in vivo with a caution that it may not be able to clearly distinguish HCC tumors from normal liver tissue.
format Online
Article
Text
id pubmed-9351703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93517032022-08-12 [(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC) Seo, Youngho Craig, Miranda C. Murphy, Stephanie T. Feng, Jinjin Chen, Xin Yuneva, Mariia Mol Imaging Research Article PURPOSE: Quantitative in vivo [(18)F]-(2S,4R)4-fluoroglutamine ([(18)F]4-FGln or more simply [(18)F]FGln) metabolic kinetic parameters are compared with activity levels of glutamine metabolism in different types of hepatocellular carcinoma (HCC). METHODS: For this study, we used two transgenic mouse models of HCC induced by protooncogenes, MYC, and MET. Biochemical data have shown that tumors induced by MYC have increased levels of glutamine metabolism compared to those induced by MET. One-hour dynamic [(18)F]FGln PET data were acquired and reconstructed for fasted MYC mice (n = 11 tumors from 7 animals), fasted MET mice (n = 8 tumors from 6 animals), fasted FVBN controls (n = 8 normal liver regions from 6 animals), nonfasted MYC mice (n = 16 tumors from 6 animals), and nonfasted FVBN controls (n = 8 normal liver regions from 3 animals). The influx rate constants (K(1)) using the one-tissue compartment model were derived for each tumor with the left ventricular blood pool input function. RESULTS: Influx rate constants were significantly higher for MYC tumors (K(1) = 0.374 ± 0.133) than for MET tumors (K(1) = 0.141 ± 0.058) under fasting conditions (P = 0.0002). Rate constants were also significantly lower for MET tumors (K(1) = 0.141 ± 0.135) than normal livers (K(1) = 0.332 ± 0.179) under fasting conditions (P = 0.0123). Fasting conditions tested for MYC tumors and normal livers did not result in any significant difference with P values > 0.005. CONCLUSION: Higher influx rate constants corresponded to elevated levels of glutamine metabolism as determined by biochemical assays. The data showed that there is a distinctive difference in glutamine metabolism between MYC and MET tumors. Our study has demonstrated the potential of [(18)F]FGln PET imaging as a tool to assess glutamine metabolism in HCC tumors in vivo with a caution that it may not be able to clearly distinguish HCC tumors from normal liver tissue. Hindawi 2022-07-25 /pmc/articles/PMC9351703/ /pubmed/35967756 http://dx.doi.org/10.1155/2022/5185951 Text en Copyright © 2022 Youngho Seo et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Seo, Youngho
Craig, Miranda C.
Murphy, Stephanie T.
Feng, Jinjin
Chen, Xin
Yuneva, Mariia
[(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
title [(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
title_full [(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
title_fullStr [(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
title_full_unstemmed [(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
title_short [(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)
title_sort [(18)f]-(2s,4r)4-fluoroglutamine pet imaging of glutamine metabolism in murine models of hepatocellular carcinoma (hcc)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351703/
https://www.ncbi.nlm.nih.gov/pubmed/35967756
http://dx.doi.org/10.1155/2022/5185951
work_keys_str_mv AT seoyoungho 18f2s4r4fluoroglutaminepetimagingofglutaminemetabolisminmurinemodelsofhepatocellularcarcinomahcc
AT craigmirandac 18f2s4r4fluoroglutaminepetimagingofglutaminemetabolisminmurinemodelsofhepatocellularcarcinomahcc
AT murphystephaniet 18f2s4r4fluoroglutaminepetimagingofglutaminemetabolisminmurinemodelsofhepatocellularcarcinomahcc
AT fengjinjin 18f2s4r4fluoroglutaminepetimagingofglutaminemetabolisminmurinemodelsofhepatocellularcarcinomahcc
AT chenxin 18f2s4r4fluoroglutaminepetimagingofglutaminemetabolisminmurinemodelsofhepatocellularcarcinomahcc
AT yunevamariia 18f2s4r4fluoroglutaminepetimagingofglutaminemetabolisminmurinemodelsofhepatocellularcarcinomahcc